Ki Summary

Reaction Details

Report a problem with these data

Target

Renin

Ligand

BDBM50434420

Substrate/Competitor

n/a

Meas. Tech.

ChEMBL_962066 (CHEMBL2388034)

IC50

1.9±n/a nM

Citation

Nakamura, Y; Fujimoto, T; Ogawa, Y; Namiki, H; Suzuki, S; Asano, M; Sugita, C; Mochizuki, A; Miyazaki, S; Tamaki, K; Nagai, Y; Inoue, S; Nagayama, T; Kato, M; Chiba, K; Takasuna, K; Nishi, T Lead optimization of 5-amino-6-(2,2-dimethyl-5-oxo-4-phenylpiperazin-1-yl)-4-hydroxyhexanamides to reduce a cardiac safety issue: discovery of DS-8108b, an orally active renin inhibitor. Bioorg Med Chem21:3175-96 (2013) [PubMed] Article

More Info.:

Get all data from this article, Assay Method

Renin

Name:

Renin

Synonyms:

Angiotensinogenase | REN | RENI_HUMAN

Type:

Enzyme

Mol. Mass.:

45058.99

Organism:

Homo sapiens (Human)

Description:

n/a

Residue:

406

Sequence:

MDGWRRMPRWGLLLLLWGSCTFGLPTDTTTFKRIFLKRMPSIRESLKERGVDMARLGPEW
SQPMKRLTLGNTTSSVILTNYMDTQYYGEIGIGTPPQTFKVVFDTGSSNVWVPSSKCSRL
YTACVYHKLFDASDSSSYKHNGTELTLRYSTGTVSGFLSQDIITVGGITVTQMFGEVTEM
PALPFMLAEFDGVVGMGFIEQAIGRVTPIFDNIISQGVLKEDVFSFYYNRDSENSQSLGG
QIVLGGSDPQHYEGNFHYINLIKTGVWQIQMKGVSVGSSTLLCEDGCLALVDTGASYISG
STSSIEKLMEALGAKKRLFDYVVKCNEGPTLPDISFHLGGKEYTLTSADYVFQESYSSKK
LCTLAIHAMDIPPPTGPTWALGATFIRKFYTEFDRRNNRIGFALAR

BDBM50434420

n/a

Name

BDBM50434420

Synonyms:

CHEMBL2387572

Type

Small organic molecule

Emp. Form.

C31H46ClFN4O4

Mol. Mass.

593.173

SMILES

CC(C)[C@H](C[C@H](O)[C@@H](N)CN1CC(=O)N(CC1(C)C)c1cc(F)ccc1Cl)C(=O)N[C@H]1C2CC3CC1C[C@](O)(C3)C2 |r,wU:5.5,3.3,30.31,wD:7.7,37.40,TLB:29:30:40.36.37:34.33.32,29:30:32:40.37.39,38:37:30:34.33.32,THB:36:35:32:40.37.39,36:37:30.35.34:32,38:37:30.35.34:32,39:37:30:34.33.32,39:33:30:40.36.37,(40.42,-16.49,;39.09,-17.26,;37.76,-16.49,;39.09,-18.8,;37.75,-19.57,;36.42,-18.8,;36.42,-17.26,;35.08,-19.56,;33.75,-18.79,;35.08,-21.1,;33.75,-21.87,;32.41,-21.1,;31.07,-21.87,;29.74,-21.11,;31.08,-23.41,;32.42,-24.18,;33.74,-23.41,;35.23,-23.81,;34.14,-24.9,;29.74,-24.19,;28.41,-23.43,;27.08,-24.2,;25.75,-23.43,;27.08,-25.74,;28.41,-26.51,;29.75,-25.74,;31.08,-26.51,;40.42,-19.57,;40.42,-21.11,;41.75,-18.8,;43.09,-19.58,;44.28,-18.3,;44.27,-16.81,;45.62,-16.34,;44.58,-17.56,;44.59,-19.16,;45.99,-19.72,;47.01,-18.44,;48.09,-19.53,;47.02,-16.91,;45.61,-18.79,)|

Structure